OAK RIDGE INVESTMENTS LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
OAK RIDGE INVESTMENTS LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$1,696,888
+46.8%
15,744
+29.2%
0.16%
+38.5%
Q1 2024$1,156,249
+3.5%
12,189
+0.6%
0.12%
-9.3%
Q4 2023$1,117,672
+61.0%
12,117
-12.4%
0.13%
+44.9%
Q3 2023$694,342
-23.0%
13,826
-3.1%
0.09%
-19.8%
Q2 2023$902,054
+35.8%
14,273
-3.3%
0.11%
+23.3%
Q1 2023$664,187
-0.3%
14,763
-2.9%
0.09%
-9.1%
Q4 2022$666,131
-37.1%
15,205
-5.4%
0.10%
-38.5%
Q3 2022$1,059,000
+32.0%
16,067
+1.2%
0.16%
+37.6%
Q2 2022$802,000
-26.7%
15,874
-7.3%
0.12%
-4.1%
Q1 2022$1,094,000
-62.0%
17,124
-36.4%
0.12%
-49.8%
Q4 2021$2,882,000
+2.5%
26,904
-1.6%
0.24%
-2.0%
Q3 2021$2,812,000
+14.3%
27,349
-2.2%
0.25%
+15.3%
Q2 2021$2,461,000
-15.1%
27,977
-6.1%
0.22%
-20.4%
Q1 2021$2,897,000
-17.2%
29,792
-4.5%
0.27%
-12.3%
Q4 2020$3,497,000
-2.3%
31,184
-19.2%
0.31%
+10.8%
Q3 2020$3,578,000
+10.5%
38,592
-7.0%
0.28%
+2.2%
Q2 2020$3,238,000
+22.3%
41,515
-8.3%
0.27%
+0.4%
Q1 2020$2,647,000
-30.1%
45,254
-4.3%
0.27%
-2.5%
Q4 2019$3,789,000
-8.2%
47,295
-15.8%
0.28%
-10.3%
Q3 2019$4,126,000
+24.5%
56,154
+59.8%
0.31%
+35.4%
Q2 2019$3,315,00035,1340.23%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders